Trials / Completed
CompletedNCT00001254
Evaluating Pancreatic Tumors in Patients With Zollinger-Ellison Syndrome
Evaluation of the Gastrinoma in Patients With Zollinger-Ellison Syndrome
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 273 (actual)
- Sponsor
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · NIH
- Sex
- All
- Age
- 18 Years – 100 Years
- Healthy volunteers
- Not accepted
Summary
This protocol concerns the approach to the localization, diagnosis of MEN1 and management of the tumor and the tissue samples in patients with Zollinger-Ellison syndrome. It details the diagnostic imaging tests to be used to localize the tumor, investigations for MEN1 the subsequent management of the tumor and tissue samples for research.
Detailed description
This protocol concerns the approach to the localization and management of the tumor in patients with Zollinger-Ellison syndrome. It details the diagnostic imaging tests to be used to localize the tumor and the subsequent management of the tumor.
Conditions
Timeline
- Start date
- 1991-10-29
- First posted
- 1999-11-04
- Last updated
- 2026-03-30
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00001254. Inclusion in this directory is not an endorsement.